Search

Openings for multiple permanent Bacteriophage Research Associates with a Marina Del Rey biotech company in focused on phage therapeutic research.

Research Tech IV (Bacteriophage) position open with ICON Government and Public Health in Silver Spring, MD.

Cristina Howard-Varona (Ohio State University) and colleagues published a new paper on phage-specific metabolic reprogramming of 'virocells' (infected cells). This work digs into the question of how phage-infected cells affect their surroun

Adaptive Phage Therapeutics was awarded a $10.2-million contract with the US Department of Defense. The funds will go toward developing PhageBank™️, the company's personalized phage therapy system, including conducting a clinical trial.

Locus Biosciences announced it has opened enrollment for a Phase 1b clinical trial evaluating a CRISPR Cas3-enhanced phage (crPhage™) product that will target E. coli causing urinary tract infections. This is the world's first controlled cl

The Phages4Cure project is a German initiative (run by the Fraunhofer ITEM at Braunschweig in partnership with the DSMZ) to develop phage cocktails to treat P. aeruginosa in the lung. Fraunhofer ITEM has been manufacturing biologics to GMP

Phages have been in the news around the world this week! Phage therapy made the cover of Maisonneuve, a quarterly Canadian magazine (subscription required), Quanta Magazine did an in-depth feature on how phage resistance evolves differently

Research Tech IV (Bacteriophage) position open with ICON Government and Public Health in Silver Spring, MD.

Openings for multiple permanent Bacteriophage Research Associates with a Marina Del Rey biotech company in focused on phage therapeutic research.

Opening for a PhD studentship in the Blower lab at Durham University, UK. This 4-year project will examine the mechanism of type IV restriction enzymes, and will feature a 9-month placement with New England Biolabs in Massachusetts.

Phages have been in the news around the world this week! Phage therapy made the cover of Maisonneuve, a quarterly Canadian magazine (subscription required), Quanta Magazine did an in-depth feature on how phage resistance evolves differently

The Phages4Cure project is a German initiative (run by the Fraunhofer ITEM at Braunschweig in partnership with the DSMZ) to develop phage cocktails to treat P. aeruginosa in the lung. Fraunhofer ITEM has been manufacturing biologics to GMP

Locus Biosciences announced it has opened enrollment for a Phase 1b clinical trial evaluating a CRISPR Cas3-enhanced phage (crPhage™) product that will target E. coli causing urinary tract infections. This is the world's first controlled cl

Adaptive Phage Therapeutics was awarded a $10.2-million contract with the US Department of Defense. The funds will go toward developing PhageBank™️, the company's personalized phage therapy system, including conducting a clinical trial.

Cristina Howard-Varona (Ohio State University) and colleagues published a new paper on phage-specific metabolic reprogramming of 'virocells' (infected cells). This work digs into the question of how phage-infected cells affect their surroun

Happy New Year, phage enthusiasts! This week, we share how we plan to help the phage research community systematize and standardize phage data collection in 2020. We spent the last year visiting phage labs and companies, and talking to phag

BBC News has listed Isabelle Carnell Holdaway's phage therapy case as one of the biggest 'Man on the Moon' breakthroughs of 2019.

A Minnesota man's leg amputation was prevented by phages from Adaptive Phage Therapeutics. News story: Star Tribune

Johnson & Johnson seeks a Microbiology Leader, Scientific Director (phage work involved).

The J. Craig Venter Institute in Rockville, MD seeks a postdoc to develop improved reverse genetic tools for viruses (phage work involved).